Abeona Therapeutics Inc.
ABEO
Revenue
3.50M
▲2.50M▲250.00%
12 Months ChangeAssets
134.00M
▲59.18M▲79.08%
3 Months ChangeLiabilities
60.76M
▼-22.95M▼-27.41%
3 Months ChangeFree Cash Flow
-15.26M
▼-3.30M▼-27.60%
12 Months ChangeRevenue/Cost Of Revenue
Revenue
Cost Of Revenue
Loading...
| Date | Revenue | Cost Of Revenue |
|---|---|---|
Net Profit/Loss
Net Profit/Loss
Baseline
Loading...
| Date | Net Profit/Loss |
|---|---|
Assets/Liabilities
Assets
Liabilities
Loading...
| Date | Assets | Liabilities |
|---|---|---|
Cash Flows
Operating (Cash Flow)
Investing (Cash Flow)
Financing (Cash Flow)
Free Cash Flow
Loading...
| Date | Operating (Cash Flow) | Investing (Cash Flow) | Financing (Cash Flow) | Free Cash Flow |
|---|---|---|---|---|
EPS
EPS (Diluted)
Loading...
| Date | EPS | EPS (Diluted) |
|---|---|---|
Outstanding Shares
Loading...
| Date | Outstanding Shares |
|---|---|
Recent 8-K/10-Q Filings
2024-10-29
Form 8-K
ID: 0001493152-24-042775
2024-08-14
Form 8-K
ID: 0001493152-24-031862
2024-08-12
Form 10-Q
ID: 0001493152-24-031150
2024-08-12
Form 8-K
ID: 0001493152-24-031146
2024-07-09
Form 8-K
ID: 0001493152-24-026640
2024-05-15
Form 10-Q
ID: 0001493152-24-019459
2024-05-15
Form 8-K
ID: 0001493152-24-019449
2024-05-03
Form 8-K
ID: 0001493152-24-017768
2024-05-03
Form 8-K
ID: 0001493152-24-017625
2024-04-24
Form 8-K
ID: 0001493152-24-015792